UniProtKB/Swiss-Prot P22570: Variant p.Val314Leu

NADPH:adrenodoxin oxidoreductase, mitochondrial
Gene: FDXR
Feedback?

Variant information Variant position:

314 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:

US The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Valine (V) to Leucine (L) at position 314 (V314L, p.Val314Leu). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:

Similar physico-chemical property. Both residues are medium size and hydrophobic. The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:

1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page
Variant description:

In MMDS9B; uncertain significance. Any additional useful information about the variant.

Sequence information Variant position:

314 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:

491 The length of the canonical sequence.
Location on the sequence:

ARQASASRAWGLRFFRSPQQ V LPSPDGRRAAGVRLAVTRLE The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         ARQASASRAWGLRFFRSPQQVL-------PSPDGRRAAGVRLAVTRL--E

Mouse                         ARQALASRAWGLRFFRSPQQVL-------PTPDGQRVAGIR

Rat                           ARRALASRAWGLRFFRSPQQVL-------PTPDGRRVAGIR

Bovine                        ARRASASRAWGLRFFRSPQQVL-------PSPDGRRAAGIR

Drosophila                    GRISGSKQFLPI-FLRAPKAIA-------P-------GEME

Slime mold                    ANNGNMNLIFH--FLRSPVELLDKYGSSSGSGDGMVLSKIK

Baker's yeast                 PPSSGYDKFWELDYLKTPLKI--------NRDDFGAINSLS

Fission yeast                 APYSKDKKCWNLEFGLTPVEIL-------G--HKGNVENVR

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	33 – 491	NADPH:adrenodoxin oxidoreductase, mitochondrial
Modified residue	310 – 310	Phosphoserine
Modified residue	317 – 317	Phosphoserine

Literature citations
FDXR-associated disease in a Chinese cohort: Unraveling expanded ocular phenotypes and genetic spectrum.
Wei X.; Li H.; Zhu T.; Yao F.; Sui R.;
Exp. Eye Res. 234:109600-109600(2023)
Cited for: VARIANTS MMDS9B VAL-128; MET-158; CYS-193; CYS-306 AND LEU-314; INVOLVEMENT IN MMDS9B;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.